BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 16801584)

  • 1. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
    Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
    Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome.
    Ozata M; Ozisik G; Caglayan S; Yesilova Z; Bingöl N; Saglam M; Turan M; Beyhan Z
    Horm Metab Res; 1998 May; 30(5):266-71. PubMed ID: 9660087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1.
    Zollner TM; Veraart JC; Wolter M; Hesse S; Villemur B; Wenke A; Werner RJ; Boehncke WH; Jost SS; Scharrer I; Kaufmann R
    Br J Dermatol; 1997 Mar; 136(3):341-4. PubMed ID: 9115912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome.
    Kübler A; Schulz G; Cordes U; Beyer J; Krause U
    Exp Clin Endocrinol; 1992; 100(3):129-32. PubMed ID: 1305064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?].
    Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M
    Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and Klinefelter's syndrome.
    Horowitz M; Wishart JM; O'Loughlin PD; Morris HA; Need AG; Nordin BE
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):113-8. PubMed ID: 1532769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prolactin secretion and thyrotrophin response to thyrotrophin releasing hormone in Klinefelter's syndrome.
    Kumanov P
    Andrologia; 1995; 27(1):41-5. PubMed ID: 7755189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Klinefelter's syndrome: diagnosis and treatment. Case report].
    Martini R
    Minerva Med; 2001 Oct; 92(5):385-92. PubMed ID: 11675582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy in Klinefelter's syndrome (a prolonged observation).
    Ruvalcaba RH
    Andrologia; 1989; 21(6):535-41. PubMed ID: 2619099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fulminant acne in Klinefelter syndrome treated with testosterone. A side effect of anti-tallness therapy].
    Hartmann AA; Burg G
    Monatsschr Kinderheilkd; 1989 Aug; 137(8):466-7. PubMed ID: 2530436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic and therapeutic aspects in Klinefelter's syndrome. Our experience].
    Allepuz Losa CA; Sánchez García J; Rodríguez Vela I; Villanueva Benedicto A; Rioja Sanz L
    Actas Urol Esp; 1990; 14(2):101-3. PubMed ID: 2378263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male hypogonadism and scleroderma.
    Nowlin NS; Zwillich SH; Brick JE; Carlson HE
    J Rheumatol; 1985 Jun; 12(3):605-6. PubMed ID: 3930721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome.
    Bizzarro A; Valentini G; Di Martino G; DaPonte A; De Bellis A; Iacono G
    J Clin Endocrinol Metab; 1987 Jan; 64(1):32-6. PubMed ID: 3097058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coumarin necrosis in Klinefelter's syndrome].
    Klemm G; Engelmann C
    Z Gesamte Inn Med; 1977 Dec; 32(24):699-700. PubMed ID: 605640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prolactin-secreting tumor in a patient with Klinefelter's syndrome: a case report.
    Pinto AC; Czepielewski MA; Gross JL; Mussio W; Lengyel AM
    J Endocrinol Invest; 1996 Apr; 19(4):248-52. PubMed ID: 8862506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
    Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
    Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects and treatment of Klinefelter's syndrome].
    Del Pozo E
    Rev Iber Endocrinol; 1968; 15(89):529-55. PubMed ID: 5759956
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement.
    Wong FH; Pun KK; Wang C
    Osteoporos Int; 1993 Jan; 3(1):3-7. PubMed ID: 8422513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of androgen on erythropoietin in patients with hypogonadism].
    Cui YG; Tong JS; Pan QQ; Di FS; Jia Y; Feng T; Liu Y; Wang XH; Zhang GY
    Zhonghua Nan Ke Xue; 2003; 9(4):248-51. PubMed ID: 12931361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.